Results 51 to 60 of about 10,218 (198)

Lethal suicidal intoxication with propafenone and diazepam: a case report [PDF]

open access: green, 2023
Shuangbing Yan   +4 more
openalex   +1 more source

Brugada-Phenocopy Induced by Propafenone Overdose and Successful Treatment: A Case Report

open access: yesBalkan Medical Journal, 2017
Background: Brugada syndrome is an inherited arrhythmogenic disease that may cause sudden cardiac death due to ventricular fibrillation in young adults. Brugada syndrome caused by propafenone intoxication has been noted rarely in the literature.
Mehmet Emre Arı, Filiz Ekici
doaj   +1 more source

Elevated Resting Heart Rate in Hospitalized Patients With Atrial Fibrillation Is Associated With Increased Cardiovascular Risk

open access: yesCardiovascular Therapeutics, Volume 2026, Issue 1, 2026.
Background Effective rate control is important in the management of atrial fibrillation (AF). However, the relationship between resting heart rate (RHR) and adverse outcomes in hospitalized patients remains uncertain. Objective This study was to evaluate the association between RHR and in‐hospital outcomes.
Kangning Han   +15 more
wiley   +1 more source

The Effect of CYP2D6 Phenotypes on the Pharmacokinetics of Propafenone: A Systematic Review and Meta-Analysis

open access: yesPharmaceutics, 2022
Propafenone (PPF) is a class 1C antiarrhythmic agent mainly metabolized by cytochrome (CYP) 2D6, CYP1A2, and CYP3A4. Previous studies have shown that CYP2D6 polymorphism influences the pharmacokinetics (PK) of PPF.
Quyen Thi Tran   +4 more
doaj   +1 more source

Pharmacologic pitfalls in heart failure: A guide to drugs that may cause or exacerbate heart failure. A European Journal of Heart Failure expert consensus document

open access: yesEuropean Journal of Heart Failure, Volume 27, Issue 12, Page 2671-2690, December 2025.
Main categories of harmful drugs in heart failure. CCB, calcium channel blocker; DPP4i, dipeptidyl peptidase‐4 inhibitor; HER2‐TT, human epidermal growth factor receptor 2‐targeted therapy; NSAID, non‐steroidal anti‐inflammatory drug; TKI, tyrosine kinase inhibitor; TZD, thiazolidinedione; VEGF Inh, vascular endothelial growth factor inhibitor.
Amr Abdin   +16 more
wiley   +1 more source

Left atrial size after cardioversion for atrial fibrillation: effect of external DC shock [PDF]

open access: yes, 2003
OBJECTIVE: The aim of this study was to evaluate the effect of external direct current (DC) shock on left atrial (LA) dimension and volumes after cardioversion for atrial fibrillation, and the relation between LA size and atrial function.
L. Bonetti   +3 more
core   +1 more source

Pharmacological cardioversion of atrial fibrillation paroxysm in elderly and senile patients at prehospital stage

open access: yesКлинический разбор в общей медицине, 2021
Atrial fibrillation (AF) is the most common heart rhythm disorder requiring treatment and is associated with an increased rate of hospitalization and death.
Andrei V. Syrov
doaj   +1 more source

The Concise Guide to PHARMACOLOGY 2025/26: G protein‐coupled receptors

open access: yesBritish Journal of Pharmacology, Volume 182, Issue S1, Page S24-S151, December 2025.
The Concise Guide to Pharmacology 2025/26 marks the seventh edition in this series of biennial publications in the British Journal of Pharmacology. Presented in landscape format, the guide provides a comparative overview of the pharmacology of drug target families. The concise nature of the Concise Guide refers to the style of presentation, being clear,
Stephen P. H. Alexander   +206 more
wiley   +1 more source

Prognostic Impact of Spontaneous Conversion to Sinus Rhythm in Patients With Symptomatic Paroxysmal Atrial Fibrillation: A Propensity‐Matched Follow‐Up Study

open access: yesJournal of Cardiovascular Electrophysiology, Volume 36, Issue 12, Page 3222-3230, December 2025.
ABSTRACT Background Paroxysmal atrial fibrillation (PAF) patients do not invariably progress to persistent AF, with a consistent group of patients showing AF regression during follow‐up. The prognostic implications of spontaneous conversion (SCV) to sinus rhythm (SR) in those patients has never been evaluated yet.
Marco Valerio Mariani   +14 more
wiley   +1 more source

Bipolar Catheter Ablation as a Key for Successful Treatment of Intramural VentricuLar Arrhythmias: Results From the Bipolar‐Kiel Study

open access: yesJournal of Cardiovascular Electrophysiology, Volume 36, Issue 11, Page 2797-2807, November 2025.
ABSTRACT Background Unipolar catheter ablation (CA) is effective in the treatment of ventricular arrhythmias but its efficacy can be limited in eliminating intramural arrhythmic origins. Bipolar ablation has emerged as a bail‐out strategy. However, currently, it is being primarily utilized after a failed ablation attempt.
Fabian Moser   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy